Ex-FBI head to lead BP investigation
NEW ORLEANS — Former FBI Director Louis Freeh was appointed on Tuesday to investigate alleged misconduct by a lawyer who helped run BP's multibillion-dollar settlement fund.
U.S. District Judge Carl Barbier issued an order naming Freeh, who now runs a consulting firm, a “special master” for the investigation. In another high-profile case, Freeh recently led a university-sanctioned probe of the Pennsylvania State University sex-abuse scandal.
Oil spill claims administrator Patrick Juneau announced last month that his office is investigating allegations that an attorney on his staff received a portion of settlement proceeds for claims he had referred to a law firm before he started working on the settlement program.
Freeh was a federal judge in New York before serving as FBI director from 1993 to 2001. He founded his consulting firm, Freeh Group International Solutions LLC, in 2007.
After being appointed, Freeh met in the judge's chambers with Barbier, BP representatives and top plaintiff attorneys. He had no comment afterward.
BP had called for an independent review of the allegations. A company spokesman said in a statement that it was pleased with the appointment to try to ensure the integrity of the claims process.
“We believe that Judge Freeh's experience on the federal bench and as director of the FBI make him ideally suited to conduct a thorough investigation into the recent allegations of unethical and potentially criminal behavior within the program,” BP spokesman Geoff Morrell said in the statement.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- VA Phoenix social worker on leave for Halloween costume
- U.S. has urged legal reforms abroad to block Islamic State recruits
- Student dies in traditional Ohio State University lake jump
- ‘Crisis mode’ near at U.S.-Mexico line as nearly 5,000 children try to cross border in October
- Video prompts calls for probe of Chicago police
- Obama signs $607B Defense bill but blasts GOP limits for Gitmo
- Ads for Nazi-themed show pulled from NYC subways
- Lawyer reveals details of arrest of ‘clock kid’ Ahmed, plans to file suit
- Email address gives FBI lead on record theft of user IDs, passwords
- U.S. troops suspended in airstrike on Afghan hospital
- Company backs away from pledge to cut drug’s $750-per-pill price